Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is -3226.05% as of the fiscal period ended Tuesday, December 31, 2019.
Limited history available
INKT EBITDA Margin has fewer than three reported periods, so a trend chart would be misleading.
EBITDA MARGIN
-3226.05%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MiNK Therapeutics, Inc.
Market Cap
$58.84M
EBITDA Margin
-3226.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$58.70M
EBITDA Margin
-99843.01%
TTM Avg
-70984.01%
3Y Avg
-70984.01%
5Y Avg
-70984.01%
Market Cap
$60.10M
EBITDA Margin
-753.96%
TTM Avg
-753.96%
3Y Avg
-753.96%
5Y Avg
-753.96%
Market Cap
$60.12M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$60.56M
EBITDA Margin
-89640.62%
TTM Avg
-44862.17%
3Y Avg
-44862.17%
5Y Avg
-44862.17%
Market Cap
$60.48M
EBITDA Margin
-270.28%
TTM Avg
-442.93%
3Y Avg
-1031.00%
5Y Avg
-861.19%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | $58.84M | -3226.05% | N/A | N/A | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $58.70M | -99843.01% | -70984.01% | -70984.01% | -70984.01% |
| OKYO Pharma Limited (OKYO)vs › | $56.98M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.10M | -753.96% | -753.96% | -753.96% | -753.96% |
| PDS Biotechnology Corporation (PDSB)vs › | $60.12M | N/A | N/A | N/A | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.56M | -89640.62% | -44862.17% | -44862.17% | -44862.17% |
| Adicet Bio, Inc. (ACET)vs › | $60.48M | -270.28% | -442.93% | -1031.00% | -861.19% |
| Aldeyra The (ALDX)vs › | $54.66M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $54.26M | -40.55% | -30.41% | -34.23% | -32.87% |
Gross Margin
0.0%
EBITDA Margin
-3226.1%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2019-12-31 | -3226.05% |
